Clinical and electrophysiologic profile of Brugada syndrome in Iranian patients

Asian Cardiovascular and Thoracic Annals

Volumn 13, Issue 3, 2005, Pages 241-246

  Haghjoo, Majid ^a   Arya, Arash ^a   Emkanjoo, Zahra ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FLECAINIDE; PROCAINAMIDE;

ADULT; AGE; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; ECG ABNORMALITY; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; IRAN; MALE; PR INTERVAL; PREDICTION; PROVOCATION TEST; QT INTERVAL; SEX DIFFERENCE; ST SEGMENT ELEVATION; THROMBOPHLEBITIS;

EID: 25844447736     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230501300311     Document Type: Article

References (20)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Alings M, Wilde A. "Brugada syndrome": clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666-73.
3. Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. Cardiovas Drugs Ther 2002;16:25-27.
4. Namiki T, Ogura T, Kuwabara Y. Five-year mortality and clinical characteristics of adult subjects with right bundle branch block and ST elevation. Circulation 1995;92(Suppl):334
5. Brugada J, Brugada R, Brugada P. Right bundle branch block and ST-segment elevation in leads V1 to V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60.
6. Atarashi H, Ogawa S, Harumi K, Hayakawa H, Sugimoto T, Okada R, et al. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigators. Am J Cardiol 1996;78:581-3.
7. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998;392:393-6.
8. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999;85:803-9.
9. Priori SG, Napolitano C, Grillo M. Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res 2001;50:218-23.
10. Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 2002;105:707-13.
11. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-70.
12. Brugada R. Use of intravenous antiarrhythmics to identify concealed Brugada syndrome. Curr Control Trial Cardiovasc Med 2000;1:45-7.
13. Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation 1993;87:562-72.
14. Krishnan SC, Antzelevitch C. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991;69:277-91.
15. Morita H, Fukushima-Kusano K, Nagase S, Takenaka-Morita S, Nishii N, Kakishita M, et al. Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2003;14:373-9.
16. Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J. Natural history of Brugada syndrome. J Cardiovasc Electrophysiol 2003;14:455-70.
17. Brugada P, Brugada J, Brugada R. The Brugada syndrome. Card Electrophysiol Rev 2002;6:45-8.
18. Mok NS, Priori SG, Napolitano C, Chan NY, Chahine M, Baroudi G. A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia. J Cardiovasc Electrophysiol 2003;14:407-11.
19. Antzelevitch C, Brugada R. Fever and the Brugada syndrome. Pacing Clin Electrophysiol 2002;25:1537-9.
20. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol 2002;25:1634-40.